SCHEMBL174986

SCHEMBL174986

Cc1cccc(NC(=O)Nc2cccc3c2CCN3)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
PKM P14618 2/20 0.52
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
MEN1 O00255 2/20 0.50
MAPT P10636 2/20 0.50
CASP3 P42574 1/20 0.50
SENP7 Q9BQF6 1/20 0.50
SENP6 Q9GZR1 1/20 0.50
TRPV1 Q8NER1 1/20 0.50
KDR P35968 8/20 0.49
ROCK2 O75116 2/20 0.49
RET P07949 2/20 0.49
FLT1 P17948 2/20 0.49
EPHA2 P29317 2/20 0.49
FLT4 P35916 2/20 0.49
FLT3 P36888 2/20 0.49
AURKB Q96GD4 2/20 0.49
AXL P30530 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL174066 0.99 KMT2A (0.51) KMT2ASMN1; SMN2PKMNPC1RAB9A
SCHEMBL174930 0.87 RAB9A (0.52) KMT2ASMN1; SMN2NPC1RAB9AMEN1
SCHEMBL4569778 0.85 MEN1 (0.53) KMT2ASMN1; SMN2NPC1RAB9AMEN1
SCHEMBL173846 0.85 STING1 (0.53) KMT2ANPC1RAB9AMEN1MAPT
SCHEMBL175118 0.84 RAB9A (0.58) KMT2ASMN1; SMN2PKMNPC1RAB9A
SCHEMBL175596 0.83 MEN1 (0.56) KMT2ASMN1; SMN2NPC1RAB9AMEN1
SCHEMBL175205 0.82 KDR (0.58) KMT2ASMN1; SMN2RAB9AMEN1MAPT
SCHEMBL174238 0.82 DDX3X (0.52) KMT2ANPC1RAB9AMEN1MAPT
SCHEMBL174936 0.80 MEN1 (0.51) KMT2ASMN1; SMN2NPC1RAB9AMEN1
SCHEMBL175262 0.79 SMN1; SMN2 (0.55) KMT2ASMN1; SMN2PKMNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611806-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Ascepion Pharmaceuticals, Inc. (CN) 2013-07-10 EP claimed
WO-2012028106-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ASCEPION PHARMACEUTICALS, INC. (CN) 2012-03-08 WO claimed
EP-2611806-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Ascepion Pharmaceuticals, Inc. (CN) 2013-07-10 EP disclosed
WO-2012028106-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ASCEPION PHARMACEUTICALS, INC. (CN) 2012-03-08 WO disclosed